However, despite affinity, albeit lower, of tirzepatide for the GLP-1 receptor, tirzepatide had no effect on body weight, food intake, fasting insulin, endogenous glucose production and insulin-stimulated glucose uptake in skeletal muscle and subcutaneous white adipose tissue of GLP-1 receptor knockout mice [89]
(2009) 297:G34860
Larsson LI, Holst J, Hakanson R, and Sundler F
The most common adverse events are transient gastrointestinal disturbances (nausea, diarrhea, constipation, vomiting) occurring predominantly during dose escalation
The Task Force for the management of arterial hypertension of the European Society of Hypertension: endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)
The most reported issues are increased nausea, vomiting, indigestion, and acid reflux